Brief: Fennec Pharmaceuticals Announces Q1 2023 Financial Results And Provides Business Update
11/05/2023 12:44
May 11 (Reuters) - Fennec Pharmaceuticals Inc FENC.O :
* FENNEC PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* FENNEC PHARMACEUTICALS INC - QTRLY NET LOSS $0.23 PER
SHARE
* FENNEC PHARMACEUTICALS INC- ANTICIPATE CASH, CASH
EQUIVALENTS AS
OF MARCH 31 SUFFICIENT TO FUND OPERATIONS FOR AT LEAST NEXT 12
MONTHS
Source text for Eikon: ID:nGNX3rVpFm
Further company coverage: FENC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fennec Pharmaceuticals
See all newsFennec Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings Summary
Fennec Pharmaceuticals Q2 sales rise on PEDMARK demand
Fennec Pharmaceuticals Inc. expected to post earnings of 1 cent a share - Earnings Preview
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand
U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple